Literature DB >> 26718393

Leishmania chagasi heparin-binding protein: Cell localization and participation in L. chagasi infection.

Thaís Viana Fialho Martins1, Thaís Vieira de Carvalho2, Claudia Vânia Miranda de Oliveira3, Sérgio Oliveira de Paula2, Sílvia Almeida Cardoso4, Leandro Licursi de Oliveira2, Eduardo de Almeida Marques-da-Silva2.   

Abstract

Visceral leishmaniasis is a fatal human disease caused by the intracellular protozoan parasite Leishmania chagasi that is captured by host cells in a process involving classics receptors mediated phagocytosis. The search for molecules involved in this process is important to design strategies to disease control. In this work, we verified the presence of heparin-binding protein (HBP) in L. chagasi promastigotes forms. HBP is a lectin of the group of ubiquitous proteins, whose main characteristic is to bind to carbohydrates present in glycoproteins or glycolipids, which is poorly studied in Leishmania species. L. chagasi HBP (HBPLc) was purified by affinity chromatography using heparin-agarose column in FPLC automated system. Its localization in the parasite was assessed by immunolabeling and electronic transmission microscopy tests using anti-HBPLc polyclonal antibodies, which showed HBP spread over the parasite outer surface and internally next to the kynetoplast. In addition, we verified that HBPLc participates in the process of parasite infection, since its blocking with heparin generated a partial reduction in the internalization of Leishmania by RAW macrophages "in vitro". According to these results, it is believed that, in further "in vivo" studies, interference on this parasitic protein may provide us prophylactic and therapeutic alternatives against visceral leishmaniasis.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Heparin; Lectins; Leishmania; Visceral leishmaniasis

Mesh:

Substances:

Year:  2015        PMID: 26718393     DOI: 10.1016/j.molbiopara.2015.12.005

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  3 in total

1.  Lipophosphoglycan 3 From Leishmania infantum chagasi Binds Heparin With Micromolar Affinity.

Authors:  Thaís Viana Fialho Martins; Ana Eliza Zeraik; Natália Oliveira Alves; Leandro Licursi de Oliveira; Tiago Antônio de Oliveira Mendes; Ricardo DeMarco; Eduardo de Almeida Marques-da-Silva
Journal:  Bioinform Biol Insights       Date:  2018-03-13

Review 2.  A Promising Candidate: Heparin-Binding Protein Steps onto the Stage of Sepsis Prediction.

Authors:  Yang Yang; Guihuan Liu; Qingnan He; Jie Shen; Linyong Xu; Ping Zhu; Mingyi Zhao
Journal:  J Immunol Res       Date:  2019-12-16       Impact factor: 4.818

Review 3.  Leishmaniasis and glycosaminoglycans: a future therapeutic strategy?

Authors:  Débora Almeida Merida-de-Barros; Suzana Passos Chaves; Celso Luis Ribeiro Belmiro; João Luiz Mendes Wanderley
Journal:  Parasit Vectors       Date:  2018-10-03       Impact factor: 3.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.